Method for increasing placental blood flow
US5888964A · kind A · utility
0Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 1996 |
| Grant date | Mar 30, 1999 |
| Priority date | — |
| Expiry date | Apr 24, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for increasing the placental blood flow, which comprises administering a human-originated antithrombin-III. The human-originated antithrombin-III increases the placental blood flow in mammals and particularly improves intrauterine growth retardation caused by a decreased blood flow. The method is highly safe to the mother and fetus, since it uses human-originated AT-III as an active ingredient, thereby enabling effective and safe treatment of intrauterine growth retardation (IUGR) and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.